Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Idiopathic myositis].

J M Burgunder1

  • 1Neurologische Klinik und Poliklinik, Universität Bern. jm.burgunder@dkf6.unibe.ch

Therapeutische Umschau. Revue Therapeutique
|September 6, 2003
PubMed
Summary

Idiopathic inflammatory myopathies, including dermatomyositis and polymyositis, require prompt diagnosis for effective treatment. Inclusion body myositis, however, presents unique challenges and may benefit from controlled muscle training.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort.

Parkinsonism & related disorders·2019
Same author

Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.

Journal of neurology·2016
Same author

EFNS review on the role of muscle biopsy in the investigation of myalgia.

European journal of neurology·2013
Same author

Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese.

Neurobiology of aging·2009
Same author

Deep brain stimulation for dystonia: outcome at long-term follow-up.

Journal of neurology·2008
Same author

Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features.

Journal of neurology·2007

Area of Science:

  • Neurology
  • Rheumatology
  • Pathology

Context:

  • Idiopathic inflammatory myopathies (IIMs) encompass dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM).
  • Diagnosis relies on clinical presentation, laboratory findings, and muscle biopsy morphology.
  • Early diagnosis is crucial for timely and effective treatment initiation and management.

Purpose:

  • To differentiate between IIM subtypes based on diagnostic criteria and treatment responses.
  • To highlight the importance of specific investigations, such as neoplasia screening in dermatomyositis.
  • To outline distinct therapeutic approaches for DM/PM versus IBM.

Summary:

  • DM and PM are often associated with neoplasia, necessitating thorough cancer screening.
  • Symptoms of DM and PM typically respond to immunomodulatory therapies.
  • IBM shows limited response to immunomodulatory treatment but may benefit from controlled muscle training to slow progression.

Impact:

  • Facilitates accurate diagnosis and subtype classification of idiopathic myositis.
  • Guides appropriate and individualized treatment strategies for different myositis types.
  • Improves patient outcomes by enabling targeted therapies and management plans.

Related Experiment Videos